h120 and 793/b type vaccine strains combination protects chickens against challenge with qx like infectious bronchitis virus

Detection of the Chinese Genotype of Infectious Bronchitis Virus (QX-type) in Iran

Case Report: Recently a 20-day-old layer flock with mortality has been submitted to the PCR Lab. Infectious Bronchitis Virus (IBV) has been detected in the clinical samples. Results: A phylogenetic tree based on a partial S1 gene sequence showed Iranian IBV variant located in LX4-type cluster. This cluster include all QXIBV-type detected in China and European countries. The highest sequence hom...

Protection of chickens against infectious bronchitis virus with a multivalent DNA vaccine and boosting with an inactivated vaccine

The protective efficacy of DNA plasmids encoding avian infectious bronchitis virus (IBV) S1, N, or M protein was investigated in chickens. Chickens were inoculated monovalently (with plasmid pVAX1-16S1, pVAX1-16M, or pVAX1-16N alone) or multivalently (combination of the three different plasmids, pVAX1-16S1/M/N). A prime-boost immunization protocol against IBV was developed. Chickens were immuni...

Isolation and Identification of Infectious Bronchitis Virus from Commercial Chickens

S1 gene sequence analysis of infectious bronchitis virus vaccinal strains (H120 & H52) and their embryo-passaged derivatives

Avian infectious bronchitis is an acute and highly contagious disease that mainly causes respiratory symptoms in poultry. A number of serotypes and variants of the viral agent with poor cross-protection are the major problem to achieve desired immunity from vaccination. The S1 subunit of S glycoprotein (spike) is the major determinant of IBV so that a minor change in amino acid sequence of this...

Vaccination against infectious bronchitis virus: A continuous challenge.

Infectious bronchitis virus (IBV) is a significant respiratory pathogen of commercial poultry that causes millions of dollars in lost revenue worldwide each year. Even though the poultry industry extensively vaccinates against IBV, emergence of new serotypes and variants continually occur, making control of the disease difficult. Current mass application strategies for IBV vaccines are ineffici...

Bivalent DNA Vaccination with Genes Encoding Leishmania major Cysteine Proteinases Type I and II Protects Mice Against Infectious Challenge